Potassium: US Caps OTC at 99 mg (Cardiac Arrest Risk)

Concentrated potassium salts can cause life-threatening hyperkalemia and cardiac arrhythmias in susceptible people, especially those with kidney disease or on ACE inhibitors and ARBs. FDA DRI potassium adequate intakes are best met primarily through food unless a clinician prescribes higher-dose replacement. Potassium is life-sustaining at physiologic levels and life-threatening in hyperkalemia when combined with ACE inhibitors, ARBs, potassium-sparing diuretics, or advanced CKD. “Lite salt” and electrolyte powders add potassium paths that patients forget to list on medication reconciliation forms. Treat each bottle as a line item with dose, frequency, and ingredient form—not only a brand name. NutriAudit normalizes units, flags duplicate nutrient paths across products, and surfaces totals that approach tolerable upper intake levels from authoritative references. Use the export as a conversation starter with your clinician before surgery, pregnancy, new prescriptions, or whenever symptoms shift alongside product changes. Retail marketing and percent daily value lines do not replace summing the same vitamin or mineral across every source you actually take in a day. Proprietary blends still leave you responsible for recognizable vitamins and minerals underneath; photograph both the marketing panel and the Supplement Facts table when you open a new bottle so later dose reconstruction does not depend on memory alone. Supplement facts panels round numbers and sometimes list proprietary blends without gram-for-gram transparency for every ingredient. That opacity matters less for trace novelty compounds and more for nutrients with defined ULs, where small per-serving amounts still become dangerous when four products share the same category. Serving size tricks also distort perception: “two tablets daily” doubles the printed per-tablet dose, and powders measured with unpacked scoops vary wildly. International units for vitamins A, D, and E require conversion before you can compare totals to milligram or microgram UL tables. If you travel or import products, label conventions differ; relying on percent daily value alone is risky because DV targets are not identical to UL ceilings. A disciplined audit writes down each product, dose, and frequency, then converts units once. Label percent daily value is a teaching tool aligned to population reference intakes, not a toxicity meter. You can be below 100% DV on every bottle yet exceed a UL when four bottles each carry 50–80% of the same nutrient. Conversely, B12 labels showing thousands of percent DV reflect absorption science, not a mandate to stack five B12 products. “Natural,” “clean,” and “pharmaceutical grade” are marketing phrases without standardized regulatory definitions for safety. Third-party testing certifications help quality-minded buyers but do not replace arithmetic on totals. If marketing claims cite a single study, ask whether that study used the same population, dose, and duration as your stack. Bleeding risk is one of the most common supplement–drug interaction themes because patients combine fish oil, high-dose vitamin E, turmeric/curcumin, garlic concentrates, ginkgo, and NSAIDs without summing antiplatelet burden. Sedation stacks layer melatonin, valerian, antihistamines, alcohol, and prescription sleep aids until morning impairment and fall risk rise, especially in older adults. Serotonergic stacking can occur when St John’s wort or high-dose tryptophan-adjacent products overlap SSRIs, SNRIs, MAOIs, or triptans. These are not “maybe someday” interactions; they are emergency-department patterns when disclosure fails. Your written stack list should include doses, brands, and start dates so clinicians can interpret symptoms temporally. Long-term supplement habits deserve periodic review the same way medications do: indications change, kidney function changes, diets change, and goals change. A seasonal vitamin D strategy at higher latitude differs from year-round megadosing without 25(OH)D monitoring. Iron repletion should have an endpoint informed by ferritin and symptoms, not infinite pills because fatigue persisted for unrelated reasons. Protein powders displace whole-food meals for some busy users, creating micronutrient gaps that another capsule cannot honestly fix. If a supplement has not produced a measurable or symptomatic benefit after a reasonable trial window, reconsider the diagnosis and the product rather than adding compensatory layers. Gut health hype popularizes probiotics, prebiotics, digestive enzymes, and fiber powders simultaneously, sometimes provoking bloating instead of relief. Post-antibiotic probiotic timing is debated; immunocompromised hosts face infection risk from live cultures; SIBO presentations worsen for some with certain strains. Pancreatic insufficiency and celiac disease require medical enzyme and diet strategies, not guesswork stacks. Acid suppression changes upper GI flora and nutrient extraction. If diarrhea is bloody, febrile, or severe, stop experimenting and seek urgent care rather than doubling probiotic CFUs. NutriAudit encourages you to export a single stack summary for clinicians whenever totals approach reference limits or when new symptoms coincide with product changes. Revisit the audit after hospital discharge, a course of antibiotics, intentional weight loss, or any sustained diet pattern shift that changes what you eat every day.